Publicacións (67) Publicacións de Faustino Mollinedo García

2021

  1. Methylsulfanylpyridine based diheteroaryl isocombretastatin analogs as potent anti-proliferative agents

    European Journal of Medicinal Chemistry, Vol. 209

  2. Neutrophils drive endoplasmic reticulum stress-mediated apoptosis in cancer cells through arginase-1 release

    Scientific Reports, Vol. 11, Núm. 1

  3. New indolesulfonamide derivatives targeting the colchicine site of tubulin: synthesis, anti-tumour activity, structure–activity relationships, and molecular modelling

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 36, Núm. 1, pp. 2025-2044

2020

  1. Potent colchicine-site ligands with improved intrinsic solubility by replacement of the 3,4,5-trimethoxyphenyl ring with a 2-methylsulfanyl-6-methoxypyridine ring

    Bioorganic Chemistry, Vol. 98

2017

  1. Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine

    PLoS Neglected Tropical Diseases, Vol. 11, Núm. 8

2016

  1. Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy

    Pharmacology and Therapeutics, Vol. 165, pp. 114-131

  2. C-Geranylated flavonoids from Paulownia tomentosa fruits with antimicrobial potential and synergistic activity with antibiotics

    Pharmaceutical Biology, Vol. 54, Núm. 8, pp. 1398-1407

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  4. Synthesis of bioconjugate sesterterpenoids with phospholipids and polyunsaturated fatty acids

    Molecules, Vol. 21, Núm. 1

  5. The alkylphospholipid edelfosine shows activity against Strongyloides venezuelensis and induces apoptosis-like cell death

    Acta Tropica, Vol. 162, pp. 180-187

2015

  1. Arginase activity and CD3ζ expression after major surgery

    Intensive Care Medicine

  2. ERK1/2 acts as a switch between necrotic and apoptotic cell death in ether phospholipid edelfosine-treated glioblastoma cells

    Pharmacological Research, Vol. 95-96, pp. 2-11

  3. Eficacia de alquil-fosfolípidos frente a Strongyloides venezuelensis

    XIX Congreso de la Sociedad Española de Parasitología (SOCEPA)

  4. Endoplasmic reticulum targeting in Ewing's sarcoma by the alkylphospholipid analog edelfosine

    Oncotarget, Vol. 6, Núm. 16, pp. 14596-14613

  5. Erratum: In Vitro and in Vivo Anti-Schistosomal Activity of the Alkylphospholipid Analog Edelfosine (PLoS ONE (2014) 9:10 (e109431) DOI: 10.1371/journal.pone.0109431)

    PLoS ONE

  6. Inhibition of granulomatous inflammation and prophylactic treatment of schistosomiasis with a combination of edelfosine and Praziquantel

    PLoS Neglected Tropical Diseases, Vol. 9, Núm. 7

  7. Lipid raft-mediated Fas/CD95 apoptotic signaling in leukemic cells and normal leukocytes and therapeutic implications

    Journal of Leukocyte Biology, Vol. 98, Núm. 5, pp. 739-759

  8. Lipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling

    Apoptosis, Vol. 20, Núm. 5, pp. 584-606

  9. Lipid rafts as major platforms for signaling regulation in cancer

    Advances in Biological Regulation, Vol. 57, pp. 130-146

  10. Triggers and signaling cross-talk controlling cell death commitment

    Cell Cycle